Core Scientific financials at a glance
| Year | Year | 2021 | 2022 | 2020 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$544.48M | $640.31M | $60.32M | $502.40M | $0.00M |
| GM % | Gross Margin % |
|
43.87% | 1.31% | 15.57% | 24.57% | 0.00% |
| OM | Operating Margin |
|
24.66% | -67.04% | -20.24% | 2.95% | 0.00% |
| EPS | Earnings Per Share |
|
$0.63 | $-0.96 | $-0.19 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0.1m | 317.28m | 0m | 0m | 177.6m |
| OCF | Operating Cash Flow |
|
$-56.74M | $205.19M | $-23.77M | $65.11M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $-396.47M | $-37.44M | $48.95M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.56 | $-1.13 | $-395.98 | $0.13 | $0.00 |